Heterologous mRNA vaccine boosters induce a stronger and longer-lasting antibody response against Omicron XBB variant.

Autor: Tay MZ; ASTAR Infectious Diseases Labs (A∗STAR ID Labs), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore., Goh YS; ASTAR Infectious Diseases Labs (A∗STAR ID Labs), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore., Fong SW; ASTAR Infectious Diseases Labs (A∗STAR ID Labs), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore., Chang ZW; ASTAR Infectious Diseases Labs (A∗STAR ID Labs), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore., Rouers A; ASTAR Infectious Diseases Labs (A∗STAR ID Labs), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore., Wong N; ASTAR Infectious Diseases Labs (A∗STAR ID Labs), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore., Torres-Ruesta A; ASTAR Infectious Diseases Labs (A∗STAR ID Labs), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore., Huang Y; ASTAR Infectious Diseases Labs (A∗STAR ID Labs), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore., Selvam SK; ASTAR Infectious Diseases Labs (A∗STAR ID Labs), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore., Hor PX; ASTAR Infectious Diseases Labs (A∗STAR ID Labs), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore., Loh CY; ASTAR Infectious Diseases Labs (A∗STAR ID Labs), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore., Wang B; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore., Mohd Salleh SN; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore., Ngoh EZX; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore., Lee RTC; Bioinformatics Institute (BII), Agency of Science, Technology and Research (ASTAR), Singapore, Singapore.; GISAID Global Data Science Initiative (GISAID), Munich, Germany., Neo V; ASTAR Infectious Diseases Labs (A∗STAR ID Labs), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore., Kam IKJ; ASTAR Infectious Diseases Labs (A∗STAR ID Labs), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore., Poh XY; National Centre for Infectious Diseases, Singapore, Singapore., Rao S; National Centre for Infectious Diseases, Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore., Chia PY; National Centre for Infectious Diseases, Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore., Ong SWX; National Centre for Infectious Diseases, Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore., Lee TH; National Centre for Infectious Diseases, Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore., Lim C; National Centre for Infectious Diseases, Singapore, Singapore., Teo J; National Centre for Infectious Diseases, Singapore, Singapore., Maurer-Stroh S; ASTAR Infectious Diseases Labs (A∗STAR ID Labs), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.; Bioinformatics Institute (BII), Agency of Science, Technology and Research (ASTAR), Singapore, Singapore.; GISAID Global Data Science Initiative (GISAID), Munich, Germany.; National Public Health Laboratory, Singapore, Singapore.; Department of Biological Sciences, National University of Singapore, Singapore, Singapore.; Human Potential Translational Research Programme, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Wang CI; Singapore Immunology Network (SIgN), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore., Leo YS; National Centre for Infectious Diseases, Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.; Saw Swee Hock School of Public Health, National University of Singapore, Singapore, Singapore.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Lin RTP; National Centre for Infectious Diseases, Singapore, Singapore.; National Public Health Laboratory, Singapore, Singapore.; Department of Microbiology and Immunology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Lye DC; National Centre for Infectious Diseases, Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.; Department of Medicine, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore., Young BE; National Centre for Infectious Diseases, Singapore, Singapore.; Department of Infectious Diseases, Tan Tock Seng Hospital, Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore., Ng LFP; ASTAR Infectious Diseases Labs (A∗STAR ID Labs), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.; National Institute of Health Research, Health Protection Research Unit in Emerging and Zoonotic Infections, University of Liverpool, Liverpool, UK.; Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, Liverpool, UK., Renia L; ASTAR Infectious Diseases Labs (A∗STAR ID Labs), Agency for Science, Technology and Research (ASTAR), Singapore, Singapore.; Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore.; School of Biological Sciences, Nanyang Technological University, Singapore, Singapore.
Jazyk: angličtina
Zdroj: The Lancet regional health. Western Pacific [Lancet Reg Health West Pac] 2023 Apr; Vol. 33, pp. 100732. Date of Electronic Publication: 2023 Mar 07.
DOI: 10.1016/j.lanwpc.2023.100732
Abstrakt: Competing Interests: A patent application for the SFB assay has been filed (Singapore patent #10202009679P: A Method Of Detecting Antibodies And Related Products) by Y.S.G., L.R., and L.F.P.N. All other authors declare no competing interests.
Databáze: MEDLINE